Rappaport Andrew

Rappaport Andrew is listed in filings as Director at Olema Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Nov 25, 2025, including 4 public disclosures. Recent filings connect the profile to Olema Pharmaceuticals, Inc. (OLMA). The current snapshot covers public activity from Jun 18, 2024 to Nov 25, 2025. Reported amounts are shown as $14.0K to $284.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.